Robotic prostatectomy in morbidly obese men is feasible, reasonably safe, and appears to provide oncologic control comparable to that achieved in a normal weight population.
Cheryl Guttman Krader
Benign PSA, measured in serum with a proprietary automated assay, improves prostate cancer detection when it is incorporated into an artificial neural network.
Percutaneous nephrolithotomy, with or without a tube, offers a high success rate in treating small or asymptomatic lower-pole stones.
Researchers are further exploring the diagnostic and prognostic utility of PCA3, and data showed that combining PCA3 with free PSA and other risk factors significantly improves the accuracy for predicting biopsy outcomes.
Use of magnetic anchoring guidance systems to facilitate single-port and natural orifice surgery yielded success in human subjects.
Results of a prospective study in which urologic surgeons at Columbia University Medical Center, New York, compared flexible fiber optic and digital cystoscopes show that with proper care, both types are durable for in-office applications.
Outcomes of studies reviewing patients who have undergone placement of a coil-based metallic ureteral stent indicate it is a viable alternative for management of benign and malignant upper urinary tract obstruction.
Researchers developing a degradable ureteral stent report progress with their project that supports moving forward into clinical trials.
Stone burden, a non-modifiable factor, was the only independent predictor associated with cost for PCNL.
Laparoscopic radical prostatectomy has a definite learning curve, but it is slower than the learning curve for open surgery and is worsened in surgeons with prior open training.